RAC 0.30% $1.67 race oncology ltd

Thanks Dr T, hopefully the secondary anti cancer endpoints get...

  1. 433 Posts.
    lightbulb Created with Sketch. 212




    Thanks Dr T, hopefully the secondary anti cancer endpoints get enough time to give us the ‘zag’ part of the equation. Although the risk of not getting enough supporting data for that does appear to be offset by earlier evidence of efficacy in multiple cancers/indications. Smaller bite but still more piece of the pie?

    One other item that came up from the AGM was the mention of China as a potential early market for bisantrene. Without knowing what shape an early pre approval deal could look like in that part of the world it does seem to be worth a shot. Interested to see if you and Pete can make anything happen there.

    Last edited by couldwellb: 07/12/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.67
Change
-0.005(0.30%)
Mkt cap ! $284.5M
Open High Low Value Volume
$1.69 $1.69 $1.65 $45.21K 27.18K

Buyers (Bids)

No. Vol. Price($)
1 3115 $1.67
 

Sellers (Offers)

Price($) Vol. No.
$1.68 414 1
View Market Depth
Last trade - 13.43pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.